Format

Send to

Choose Destination
J Allergy Clin Immunol. 2019 Apr 23. pii: S0091-6749(19)30524-X. doi: 10.1016/j.jaci.2019.04.006. [Epub ahead of print]

Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant.

Author information

1
Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio; Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Host Defense Program, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio; Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address: jeffery.auletta@nationwidechildrens.org.
2
Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Center for Perinatal Research and Neonatology, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
3
Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio; Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
4
Division of Hematology, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio; Cell Therapy Laboratory, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus, Ohio.
5
Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio; Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
6
Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Host Defense Program, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
7
Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
8
Center for Perinatal Research and Neonatology, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
9
Laboratory of Microbiology/Immunoserology, Nationwide Children's Hospital, Columbus, Ohio.
10
Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio.
11
Cell Therapy Laboratory, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus, Ohio.
12
Clinical Pharmacy, Nationwide Children's Hospital, Columbus, Ohio.
13
Ohio State University Wexner Medical Center, Columbus, Ohio.
14
Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.
15
Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio.
16
Drug and Device Development Services, Nationwide Children's Hospital, Columbus, Ohio.
17
Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio; Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
PMID:
31026470
DOI:
10.1016/j.jaci.2019.04.006

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center